Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du(Southeast University), Christine M. Lovly(Dana-Farber Cancer Institute)
Cited by 1,053
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|572
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
|Cancer Immunology Research|2016|493